Across 18 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Browse the complete record of transactions filed by Xilas Andrew, Chief Executive Officer. Officer active across 1 company, notably STERIS plc. Cumulatively, 20 disclosures have been published. Activity tracked since 1 October 2021. The latest transaction was disclosed on 31 May 2024 (Retenue fiscale). Regulator: SEC (Form 4). The full history is openly available.
Andrew Xilas is the Senior Vice President and General Manager, Dental at STERIS plc. He is responsible for the strategic direction of the company's dental division, which specializes in dental care solutions. Andrew plays a crucial role in optimizing operations and enhancing customer experience while supporting STERIS's growth in the market.